Explore the exciting world of Kiniksa Pharmaceuticals (KNSA 1.39%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of May 28, 2025. The video was published on Jul. 2, 2025.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth
By Motley Fool YouTube
–
Jul 2, 2025 at 7:00PM
NASDAQ: KNSA
Kiniksa Pharmaceuticals International, Plc
Market Cap
$2B
Today's Change
(1.39%) $0.38
Current Price
$27.82
Price as of July 3, 2025, 12:58 p.m. ET
Anand Chokkavelu, CFA has no position in any of the stocks mentioned. Karl Thiel has no position in any of the stocks mentioned. Keith Speights has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kiniksa Pharmaceuticals International, Plc. The Motley Fool has a disclosure policy.
Stocks Mentioned
Kiniksa Pharmaceuticals International, Plc
KNSA
$27.82
(1.39%)
$0.38
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Kiniksa Pharm's Revenue Surges 67% in Q3
Why Shares of Kiniksa Pharmaceuticals Jumped Tuesday
3 Top Biotech Stocks to Buy in February
Why Canopy Growth, Kiniksa Pharmaceuticals, and Paycom Software Jumped Today
Here's Why Kiniksa Pharmaceuticals Rose as Much as 36.7% Today
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.